# Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers

> **NCT03748758** · PHASE1 · COMPLETED · sponsor: **Novus Therapeutics, Inc** · enrollment: 30 (actual)

## Conditions studied

- Healthy Adult Volunteers

## Interventions

- **COMBINATION_PRODUCT:** Drug: OP0201
- **COMBINATION_PRODUCT:** Drug: Placebo

## Key facts

- **NCT ID:** NCT03748758
- **Lead sponsor:** Novus Therapeutics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-27
- **Primary completion:** 2019-03-20
- **Final completion:** 2019-03-20
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03748758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03748758, "Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT03748758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*